Form 8-K - Current report:
SEC Accession No. 0001193125-25-155885
Filing Date
2025-07-07
Accepted
2025-07-07 08:39:26
Documents
38
Period of Report
2025-07-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d98157d8k.htm   iXBRL 8-K 32849
2 EX-99.1 d98157dex991.htm EX-99.1 20736
3 EX-99.2 d98157dex992.htm EX-99.2 24888
7 GRAPHIC g98157ex99_2s10g1.jpg GRAPHIC 146330
8 GRAPHIC g98157ex99_2s11g1.jpg GRAPHIC 75497
9 GRAPHIC g98157ex99_2s12g1.jpg GRAPHIC 88093
10 GRAPHIC g98157ex99_2s13g1.jpg GRAPHIC 102945
11 GRAPHIC g98157ex99_2s14g1.jpg GRAPHIC 93616
12 GRAPHIC g98157ex99_2s15g1.jpg GRAPHIC 37053
13 GRAPHIC g98157ex99_2s16g1.jpg GRAPHIC 90698
14 GRAPHIC g98157ex99_2s17g1.jpg GRAPHIC 85180
15 GRAPHIC g98157ex99_2s18g1.jpg GRAPHIC 75530
16 GRAPHIC g98157ex99_2s19g1.jpg GRAPHIC 89035
17 GRAPHIC g98157ex99_2s1g1.jpg GRAPHIC 45905
18 GRAPHIC g98157ex99_2s20g1.jpg GRAPHIC 61947
19 GRAPHIC g98157ex99_2s21g1.jpg GRAPHIC 71194
20 GRAPHIC g98157ex99_2s22g1.jpg GRAPHIC 61291
21 GRAPHIC g98157ex99_2s23g1.jpg GRAPHIC 85778
22 GRAPHIC g98157ex99_2s24g1.jpg GRAPHIC 25312
23 GRAPHIC g98157ex99_2s2g1.jpg GRAPHIC 243530
24 GRAPHIC g98157ex99_2s3g1.jpg GRAPHIC 81312
25 GRAPHIC g98157ex99_2s4g1.jpg GRAPHIC 43704
26 GRAPHIC g98157ex99_2s5g1.jpg GRAPHIC 97549
27 GRAPHIC g98157ex99_2s6g1.jpg GRAPHIC 61834
28 GRAPHIC g98157ex99_2s7g1.jpg GRAPHIC 108930
29 GRAPHIC g98157ex99_2s8g1.jpg GRAPHIC 59910
30 GRAPHIC g98157ex99_2s9g1.jpg GRAPHIC 63021
  Complete submission text file 0001193125-25-155885.txt   2966662

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kalv-20250707.xsd EX-101.SCH 2852
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20250707_lab.xml EX-101.LAB 18756
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20250707_pre.xml EX-101.PRE 11711
40 EXTRACTED XBRL INSTANCE DOCUMENT d98157d8k_htm.xml XML 3775
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 251107058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)